Share chart Outset Medical, Inc.
About
Компания Medical, Inc., занимающаяся медицинскими технологиями, разрабатывает систему гемодиализа для диализа. Он предлагает Tablo, аппарат для диализа, который позволяет проводить диализную терапию в острых и хронических условиях. Tablo включает в себя компактную консоль с интегрированной очисткой воды, производством диализата по требованию, программным обеспечением и возможностями подключения. Компания ранее была известна как Home Dialysis Plus, Ltd. и в январе 2015 года сменила свое название на Earthless Medical, Inc. Компания Emergency Medical, Inc.
More details| P/S | 46.21 |
|---|---|
| P/BV | 7.02 |
| EV/EBITDA | 0.1194 |
| EBITDA | -0.0659 |
| Цена ао | 0.69 |
| Сайт | http://www.outsetmedical.com |
| Число акций ао | 0.04959 млрд |
| Выручка | 0.0151 |
| Див.доход ао | 0 |
| ISIN | US6901451079 |
| Change price per day: | +0% (0.7085) |
|---|---|
| Change price per week: | +14.4% (0.6193) |
| Change price per month: | -80.9% (3.71) |
| Change price per 3 month: | -81.69% (3.87) |
| Change price per half year: | -80.64% (3.66) |
| Change price per year: | -94.76% (13.53) |
| Change price per 3 year: | -98.59% (50.08) |
| Change price per year to date: | -88.27% (6.04) |
All parameters ⇨
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
|---|---|---|---|---|---|---|---|---|---|
| 15.08.2024 | 15.08.2024 | Ahmed Nabeel Chief Financial Officer |
Sale | 0.84 | 3 336 | 3971 | 0 | -0.01 | link |
| 15.08.2024 | 15.08.2024 | Brottem John L. General Counsel |
Sale | 0.84 | 2 529 | 3011 | 0 | -0.01 | link |
| 15.08.2024 | 15.08.2024 | Nash Marc SVP Operations and R&D |
Sale | 0.84 | 1 086 | 1293 | 0 | 0 | link |
| 15.08.2024 | 15.08.2024 | Trigg Leslie Chair and CEO |
Sale | 0.84 | 4 459 | 5308 | 0 | -0.01 | link |
| 24.07.2024 | 24.07.2024 | Nash Marc SVP Operations and R&D |
Sale | 4.02 | 2 906 | 723 | 0 | 0 | link |
| 16.01.2024 | 17.01.2024 | Brottem John L. General Counsel |
Sale | 4.29 | 6 349 | 1480 | 0 | 0 | link |
| 16.01.2024 | 17.01.2024 | Nash Marc SVP Operations and R&D |
Sale | 429 | 290 862 | 678 | 0 | 0 | link |
| 16.01.2024 | 17.01.2024 | Porter Stacey L. Chief People Officer |
Sale | 4.29 | 3 295 | 768 | 0 | 0 | link |
| 16.01.2024 | 17.01.2024 | Racine Jean-Olivier Chief Technology Officer |
Sale | 4.29 | 3 102 | 723 | 0 | 0 | link |
| 16.01.2024 | 17.01.2024 | Trigg Leslie Chair and CEO |
Sale | 4.29 | 34 861 | 8126 | 0 | -0.02 | link |
| 16.01.2024 | 17.01.2024 | Williamson Steven S. Chief Commercial Officer |
Sale | 4.29 | 4 273 | 996 | 0 | 0 | link |
| 08.01.2024 | 08.01.2024 | Ahmed Nabeel Chief Financial Officer |
Sale | 5.49 | 58 792 | 10709 | 0 | -0.02 | link |
| 08.01.2024 | 08.01.2024 | Brottem John L. General Counsel |
Sale | 5.49 | 40 319 | 7344 | 0 | -0.02 | link |
| 08.01.2024 | 08.01.2024 | Porter Stacey L. Chief People Officer |
Sale | 5.49 | 26 165 | 4766 | 0 | -0.01 | link |
| 08.01.2024 | 08.01.2024 | Racine Jean-Olivier Chief Technology Officer |
Sale | 5.49 | 21 438 | 3905 | 0 | -0.01 | link |
| 08.01.2024 | 08.01.2024 | Trigg Leslie Chair and CEO |
Sale | 5.49 | 77 892 | 14188 | 0 | -0.03 | link |
| 08.01.2024 | 08.01.2024 | Williamson Steven S. Chief Commercial Officer |
Sale | 5.49 | 38 732 | 7055 | 0 | -0.01 | link |
| 01.09.2023 | 05.09.2023 | Ahmed Nabeel Chief Financial Officer |
Sale | 13.61 | 7 417 | 545 | 0 | 0 | link |
| 01.03.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Sale | 22.33 | 111 650 | 5000 | 0 | -0.01 | link |
| 01.03.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Purchase | 3.88 | 19 400 | 5000 | 0 | 0.01 | link |
| 01.03.2023 | 02.03.2023 | Trigg Leslie Chair and CEO |
Sale | 22.48 | 674 400 | 30000 | 0 | -0.06 | link |
| 01.03.2023 | 02.03.2023 | Trigg Leslie Chair and CEO |
Purchase | 3.88 | 116 400 | 30000 | 0 | 0.06 | link |
| 02.02.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Sale | 30 | 585 000 | 19500 | 0 | -0.04 | link |
| 02.02.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Purchase | 3.88 | 75 660 | 19500 | 0 | 0.04 | link |
| 01.02.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Sale | 27.91 | 139 550 | 5000 | 0 | -0.01 | link |
| 01.02.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Purchase | 3.88 | 19 400 | 5000 | 0 | 0.01 | link |
| 01.02.2023 | 02.02.2023 | Trigg Leslie Chair and CEO |
Sale | 28.06 | 841 800 | 30000 | 0 | -0.06 | link |
| 01.02.2023 | 02.02.2023 | Trigg Leslie Chair and CEO |
Purchase | 3.88 | 116 400 | 30000 | 0 | 0.06 | link |
| 01.12.2022 | 02.12.2022 | Trigg Leslie Chair and CEO |
Sale | 20.85 | 625 500 | 30000 | 0 | -0.06 | link |
| 01.12.2022 | 02.12.2022 | Trigg Leslie Chair and CEO |
Purchase | 3.88 | 116 400 | 30000 | 0 | 0.06 | link |
| 01.12.2022 | 02.12.2022 | Vazquez Martin Chief Operating Officer |
Sale | 20.85 | 104 250 | 5000 | 0 | -0.01 | link |
| 01.12.2022 | 02.12.2022 | Vazquez Martin Chief Operating Officer |
Purchase | 3.88 | 19 400 | 5000 | 0 | 0.01 | link |
| 25.10.2022 | 26.10.2022 | Porter Stacey L. Chief People Officer |
Sale | 15.02 | 1 968 | 131 | 0 | 0 | link |
| 19.07.2022 | 19.07.2022 | Ahmed Nabeel Chief Financial Officer |
Sale | 16.56 | 13 033 | 787 | 0 | 0 | link |
| 17.05.2022 | 17.05.2022 | Brottem John L. General Counsel |
Sale | 26.36 | 9 200 | 349 | 0 | 0 | link |
| 17.05.2022 | 17.05.2022 | Ahmed Nabeel Chief Financial Officer |
Sale | 26.36 | 3 163 | 120 | 0 | 0 | link |
| 17.05.2022 | 17.05.2022 | Porter Stacey L. Chief People Officer |
Sale | 26.36 | 2 768 | 105 | 0 | 0 | link |
| 17.05.2022 | 17.05.2022 | Trigg Leslie Chair and CEO |
Sale | 26.36 | 23 961 | 909 | 0 | 0 | link |
| 17.05.2022 | 17.05.2022 | Vazquez Martin Chief Operating Officer |
Sale | 26.36 | 6 801 | 258 | 0 | 0 | link |
| 18.04.2022 | 18.04.2022 | Brottem John L. General Counsel |
Sale | 43.25 | 104 449 | 2415 | 0 | -0.01 | link |
| 18.04.2022 | 18.04.2022 | Brottem John L. General Counsel |
Purchase | 9.48 | 22 894 | 2415 | 0 | 0.01 | link |
| 15.03.2022 | 15.03.2022 | Brottem John L. General Counsel |
Sale | 38.59 | 254 154 | 6586 | 0 | -0.01 | link |
| 15.03.2022 | 15.03.2022 | Brottem John L. General Counsel |
Purchase | 9.48 | 62 435 | 6586 | 0 | 0.01 | link |
| 09.03.2022 | 15.03.2022 | Porter Stacey L. Chief People Officer |
Sale | 41.72 | 17 356 | 416 | 0 | 0 | link |
| 25.01.2022 | 25.01.2022 | Williamson Steven S. Chief Commercial Officer |
Sale | 37.74 | 86 047 | 2280 | 0 | 0 | link |
| Institutions | Volume | Share, % |
|---|---|---|
| FMR, LLC | 7066782 | 13.99 |
| JP Morgan Chase & Company | 4961199 | 9.82 |
| Vanguard Group Inc | 3941367 | 7.8 |
| Morgan Stanley | 3868064 | 7.66 |
| Blackrock Inc. | 3795419 | 7.51 |
| T. Rowe Price Investment Management, Inc. | 3166747 | 6.27 |
| Ameriprise Financial, Inc. | 2982490 | 5.91 |
| Braidwell LP | 2400427 | 4.75 |
| Bellevue Group AG | 1760134 | 3.49 |
| Mubadala Investment Co PJSC | 1440601 | 2.85 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Leslie L. Trigg | President, CEO & Chairman | 1.22M | 1971 (53 years) |
| Mr. John L. Brottem | General Counsel & Secretary | 594.15k | 1975 (49 years) |
| Nicole Shannon | Director of Marketing Communications | N/A | |
| Dr. Michael Aragon M.D. | Chief Medical Officer | N/A | |
| Mr. Nabeel Ahmed | Chief Financial Officer | 654.74k | 1976 (48 years) |
| Mr. Jean-Olivier Racine | Chief Technology Officer | 540.93k | 1982 (42 years) |
| Mr. James S. Mazzola | Head of Investor Relations | N/A | |
| Mr. Marc Nash | Senior Vice President of Operations and R&D | N/A | 1989 (35 years) |
| Mr. Mark Gordon M.S. | Chief Regulatory & Quality Officer | N/A | 1957 (67 years) |
Address: United States, San Jose, CA , 3052 Orchard Drive - open in Google maps, open in Yandex maps
Website: http://www.outsetmedical.com
Website: http://www.outsetmedical.com
